A Double-Blind, Randomised, Exploratory Study to Investigate the Safety, Efficacy and Pharmacokinetics of PRX167700 in Subjects With Knee Osteoarthritis.
Latest Information Update: 07 Nov 2021
Price :
$35 *
At a glance
- Drugs PRX 167700 (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Sponsors Proximagen
- 25 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 21 Aug 2014 Planned End Date changed from 1 Jun 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov record.
- 21 Aug 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.